{"id":26690,"date":"2025-12-19T10:55:34","date_gmt":"2025-12-19T09:55:34","guid":{"rendered":"https:\/\/www.unither-pharma.com\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"modified":"2026-07-02T12:27:15","modified_gmt":"2026-07-02T10:27:15","slug":"pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo","status":"publish","type":"post","link":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","title":{"rendered":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO"},"content":{"rendered":"<style>\na {\n    text-decoration: none;\n    color: #464feb;\n}\ntr th, tr td {\n    border: 1px solid #e6e6e6;\n}\ntr th {\n    background-color: #f5f5f5;\n}\n<\/style>\n<div>\n<h3>Le Club Sant\u00e9 Chine d\u00e9crypte les mutations du march\u00e9 pharmaceutique chinois<\/h3>\n<p>Le mois dernier, le Club Sant\u00e9 Chine r\u00e9unissait les acteurs fran\u00e7ais engag\u00e9s sur le march\u00e9 chinois afin d\u2019analyser les grandes tendances qui red\u00e9finissent la sant\u00e9 mondiale : digitalisation, silver economy et nouvelles dynamiques industrielles.<\/p>\n<p>Invit\u00e9e de cette rencontre, <strong>Ni Zeng, Responsable de la valorisation des services Innovation et D\u00e9veloppement chez Unither Pharmaceuticals<\/strong>, a partag\u00e9 son analyse d\u2019un march\u00e9 devenu strat\u00e9gique pour les entreprises pharmaceutiques et les CDMO engag\u00e9es dans des d\u00e9marches de co-d\u00e9veloppement.<\/p>\n<h3>Pourquoi la Chine est-elle un march\u00e9 important pour Unither ?<\/h3>\n<p>La Chine est un march\u00e9 cl\u00e9 pour Unither. Depuis l\u2019ouverture de sa premi\u00e8re filiale \u00e0 Wuhan en 2016 et l\u2019acquisition d\u2019un site de production \u00e0 Nanjing en 2020, l\u2019entreprise poursuit son d\u00e9veloppement afin de r\u00e9pondre aux besoins croissants du march\u00e9, notamment dans les domaines de l\u2019ophtalmologie et des traitements des maladies respiratoires.<\/p>\n<h3>Quel impact ont les politiques nationales sur l\u2019industrie pharmaceutique locale ?<\/h3>\n<p>Chez Unither, nous observons que les politiques nationales visant \u00e0 renforcer l\u2019\u00e9valuation de l\u2019efficacit\u00e9 et de la qualit\u00e9 des m\u00e9dicaments g\u00e9n\u00e9riques, ainsi que la politique de <strong>Volume-Based Procurement (VBP)<\/strong>, encouragent les laboratoires chinois \u00e0 diff\u00e9rencier davantage leurs produits et \u00e0 investir dans l\u2019innovation.<\/p>\n<h3>Quelles sont les particularit\u00e9s du march\u00e9 ophtalmique chinois ?<\/h3>\n<p>Le march\u00e9 chinois des m\u00e9dicaments ophtalmiques d\u00e9passe aujourd\u2019hui <strong>40 milliards de yuans<\/strong>, malgr\u00e9 l\u2019impact du VBP.<\/p>\n<p>La majorit\u00e9 des collyres commercialis\u00e9s en Chine sont encore conditionn\u00e9s en flacons multidoses contenant des conservateurs, susceptibles d\u2019entra\u00eener des effets ind\u00e9sirables en cas d\u2019utilisation r\u00e9p\u00e9t\u00e9e. Le passage aux formats unidoses sans conservateur r\u00e9pond ainsi \u00e0 un besoin m\u00e9dical identifi\u00e9 tout en contribuant aux strat\u00e9gies de diff\u00e9renciation de nombreux laboratoires.<\/p>\n<h3>Comment Unither accompagne-t-il ces besoins croissants ?<\/h3>\n<p>Unither a d\u00e9j\u00e0 investi dans <strong>quatre lignes de production BFS<\/strong>, repr\u00e9sentant une capacit\u00e9 de <strong>400 millions de doses par an<\/strong>, afin d\u2019accompagner le d\u00e9veloppement de ses clients chinois et internationaux sur le march\u00e9 local.<\/p>\n<p>L\u2019entreprise pr\u00e9voit de <strong>doubler cette capacit\u00e9 au cours des cinq prochaines ann\u00e9es<\/strong> afin de r\u00e9pondre \u00e0 la croissance de la demande.<\/p>\n<h3>Comment voyez-vous la transformation du secteur pharmaceutique chinois ?<\/h3>\n<p>Comme cela a \u00e9t\u00e9 soulign\u00e9 lors de la table ronde, la Chine est pass\u00e9e du statut de simple fabricant de m\u00e9dicaments g\u00e9n\u00e9riques \u00e0 celui d\u2019acteur majeur dans le d\u00e9veloppement de m\u00e9dicaments innovants.<\/p>\n<h3>Qu\u2019est-ce que cela repr\u00e9sente pour Unither en tant que CDMO et partenaire de co-d\u00e9veloppement ?<\/h3>\n<p>Pour Unither, cette \u00e9volution constitue une opportunit\u00e9 importante, tant pour ses activit\u00e9s de CDMO sur le march\u00e9 chinois que pour le d\u00e9veloppement de partenariats de co-d\u00e9veloppement permettant aux entreprises pharmaceutiques chinoises d\u2019introduire de nouveaux produits innovants sur les march\u00e9s internationaux.<\/p>\n<p><strong>Vous souhaitez en savoir plus sur nos services de co-d\u00e9veloppement et d\u2019out-licensing ? Contactez-nous.<\/strong><\/p>\n<h2><\/h2>\n<h2>\u00c0 propos d\u2019Unither Pharmaceuticals<\/h2>\n<p>Unither Pharmaceuticals est une CDMO pharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement et la fabrication de formulations liquides en <strong>unidoses et multidoses<\/strong>, notamment des collyres, des solutions salines, des m\u00e9dicaments pour l\u2019asthme en unidoses BFS ainsi que des sticks buvables.<\/p>\n<p>Avec <strong>2 305 collaborateurs<\/strong>, <strong>huit sites de production<\/strong> r\u00e9partis en France, aux \u00c9tats-Unis, au Br\u00e9sil et en Chine, ainsi qu\u2019un centre de R&amp;D en France, Unither Pharmaceuticals a r\u00e9alis\u00e9 un chiffre d\u2019affaires de <strong>522 millions d\u2019euros en 2024<\/strong>.<\/p>\n<p>Site web : <strong>www.unither-pharma.com<\/strong>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le Club Sant\u00e9 Chine d\u00e9crypte les mutations du march\u00e9 pharmaceutique chinois Le mois dernier, le Club Sant\u00e9 Chine r\u00e9unissait les acteurs fran\u00e7ais engag\u00e9s sur le march\u00e9 chinois afin d\u2019analyser les grandes tendances qui red\u00e9finissent la sant\u00e9 mondiale : digitalisation, silver economy et nouvelles dynamiques industrielles. Invit\u00e9e de cette rencontre, Ni Zeng, Responsable de la valorisation [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":26941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-26690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-informations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither<\/title>\n<meta name=\"description\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta property=\"og:description\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\" \/>\n<meta property=\"og:site_name\" content=\"Unither\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-19T09:55:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-02T10:27:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"406\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:site\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\"},\"headline\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO\",\"datePublished\":\"2025-12-19T09:55:34+00:00\",\"dateModified\":\"2026-07-02T10:27:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"},\"wordCount\":606,\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"articleSection\":[\"Informations\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\",\"name\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"datePublished\":\"2025-12-19T09:55:34+00:00\",\"dateModified\":\"2026-07-02T10:27:15+00:00\",\"description\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"width\":406,\"height\":300,\"caption\":\"Article - Chine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unither-pharma.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"name\":\"Unither\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\",\"name\":\"Unither\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"width\":514,\"height\":252,\"caption\":\"Unither\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/UnitherPharma\",\"https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/\",\"https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/www.unither-pharma.com\"],\"url\":\"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","og_locale":"fr_FR","og_type":"article","og_title":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","og_description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","og_url":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","og_site_name":"Unither","article_published_time":"2025-12-19T09:55:34+00:00","article_modified_time":"2026-07-02T10:27:15+00:00","og_image":[{"width":406,"height":300,"url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@UnitherPharma","twitter_site":"@UnitherPharma","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#article","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"author":{"name":"admin","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28"},"headline":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO","datePublished":"2025-12-19T09:55:34+00:00","dateModified":"2026-07-02T10:27:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"wordCount":606,"publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","articleSection":["Informations"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","url":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","name":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","datePublished":"2025-12-19T09:55:34+00:00","dateModified":"2026-07-02T10:27:15+00:00","description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","breadcrumb":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","width":406,"height":300,"caption":"Article - Chine"},{"@type":"BreadcrumbList","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unither-pharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO"}]},{"@type":"WebSite","@id":"https:\/\/www.unither-pharma.com\/fr\/#website","url":"https:\/\/www.unither-pharma.com\/fr\/","name":"Unither","description":"","publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.unither-pharma.com\/fr\/#organization","name":"Unither","url":"https:\/\/www.unither-pharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","width":514,"height":252,"caption":"Unither"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UnitherPharma","https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/","https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA"]},{"@type":"Person","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28","name":"admin","sameAs":["https:\/\/www.unither-pharma.com"],"url":"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=26690"}],"version-history":[{"count":2,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690\/revisions"}],"predecessor-version":[{"id":32905,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690\/revisions\/32905"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media\/26941"}],"wp:attachment":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=26690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=26690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=26690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}